Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
BLRX
BLRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BLRX News
Today's Options Volatility and Implied Earnings Changes - November 24, 2025
Nov 24 2025
TipRanks
Options Volatility and Projected Earnings Changes for the Week of November 24 – November 26, 2025
Nov 24 2025
TipRanks
BioLineRx Reports GAAP EPS of $0.00, Exceeding Expectations by $0.54; Revenue of $0.43M Falls Short by $0.24M
Nov 24 2025
SeekingAlpha
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 24 2025
PRnewswire
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
Nov 18 2025
PRnewswire
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
Nov 17 2025
PRnewswire
BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers
Sep 29 2025
PRnewswire
Options Volatility and Implied Earnings Moves Today, August 14, 2025
Aug 14 2025
TipRanks
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 14 2025
PRnewswire
BioLineRx to Report Second Quarter 2025 Results on August 14, 2025
Aug 07 2025
PRnewswire
Jones Trading Upgrades BioLineRx - Depositary Receipt () (BLRX)
May 31 2025
NASDAQ.COM
Dow Edges Higher; Dell Shares Fall After Q1 Results
May 30 2025
Benzinga
Why Is Nano-Cap BioLineRx Stock Surging On Friday?
May 30 2025
Benzinga
Nasdaq Down 100 Points; Chicago PMI Dips In May
May 30 2025
Benzinga
BioLineRx Reports Promising Motixafortide Combo Data In PDAC Ahead Of ASCO 2025
May 30 2025
NASDAQ.COM
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
May 30 2025
Benzinga
Show More News
